These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A. Van de Bittner GC; Van de Bittner KC; Wey HY; Rowe W; Dharanipragada R; Ying X; Hurst W; Giovanni A; Alving K; Gupta A; Hoekman J; Hooker JM ACS Chem Neurosci; 2018 Feb; 9(2):358-368. PubMed ID: 29035509 [TBL] [Abstract][Full Text] [Related]
7. Intranasal insulin and orexins to treat age-related cognitive decline. Erichsen JM; Calva CB; Reagan LP; Fadel JR Physiol Behav; 2021 May; 234():113370. PubMed ID: 33621561 [TBL] [Abstract][Full Text] [Related]
8. Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system. Stanley EM; Fadel J Synapse; 2012 May; 66(5):445-52. PubMed ID: 22213437 [TBL] [Abstract][Full Text] [Related]
9. Sleep, Orexin and Cognition. Toor B; Ray LB; Pozzobon A; Fogel SM Front Neurol Neurosci; 2021; 45():38-51. PubMed ID: 34052810 [TBL] [Abstract][Full Text] [Related]
10. Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain. Zhang LN; Yang C; Ouyang PR; Zhang ZC; Ran MZ; Tong L; Dong HL; Liu Y Neuropeptides; 2016 Aug; 58():7-14. PubMed ID: 26919917 [TBL] [Abstract][Full Text] [Related]
11. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation. Modi HR; Wang Q; Gd S; Sherman D; Greenwald E; Savonenko AV; Geocadin RG; Thakor NV PLoS One; 2017; 12(9):e0182707. PubMed ID: 28957432 [TBL] [Abstract][Full Text] [Related]
12. The orexin story, sleep and sleep disturbances. Pizza F; Barateau L; Dauvilliers Y; Plazzi G J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789 [TBL] [Abstract][Full Text] [Related]
14. Sleep disorders, obesity, and aging: the role of orexin. Nixon JP; Mavanji V; Butterick TA; Billington CJ; Kotz CM; Teske JA Ageing Res Rev; 2015 Mar; 20():63-73. PubMed ID: 25462194 [TBL] [Abstract][Full Text] [Related]
15. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. Deadwyler SA; Porrino L; Siegel JM; Hampson RE J Neurosci; 2007 Dec; 27(52):14239-47. PubMed ID: 18160631 [TBL] [Abstract][Full Text] [Related]
16. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823 [TBL] [Abstract][Full Text] [Related]
17. Aging-related alterations in orexin/hypocretin modulation of septo-hippocampal amino acid neurotransmission. Stanley EM; Fadel JR Neuroscience; 2011 Nov; 195():70-9. PubMed ID: 21884758 [TBL] [Abstract][Full Text] [Related]
18. Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans. Meusel M; Voß J; Krapalis A; Machleidt F; Vonthein R; Hallschmid M; Sayk F J Neurophysiol; 2022 Feb; 127(2):548-558. PubMed ID: 35044844 [TBL] [Abstract][Full Text] [Related]
19. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. Sun Y; Tisdale RK; Kilduff TS Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813 [TBL] [Abstract][Full Text] [Related]
20. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Chen Q; de Lecea L; Hu Z; Gao D Med Res Rev; 2015 Jan; 35(1):152-97. PubMed ID: 25044006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]